Track and help Medicare patients over age 65
This trial follows people age 65 and older who are enrolled in Medicare Advantage. It aims to understand needs over time and test ways to support patients and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 65 years old or older
- Be enrolled in Medicare Advantage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help identify and manage health issues in older adults who are moderately frail. If you are 60 or older and a patient at a participating polyclinic, the program may help you stay independent and healthy.
This study tests whether nurses can help older adults stay strong and independent through regular phone calls and guidance. You'll receive support from a nurse over the telephone to manage weakness and prevent health decline.
This study tests whether a lifestyle intervention can help prevent frailty and age-related health problems. If you are between 60 and 90 years old, have some signs of frailty, and can use a mobile app with help, you may be able to join.
This study looks at how to better understand and predict frailty and memory changes in older adults with at least one chronic condition. It aims to use a simple screening to personalize care and help you stay independent longer.
This trial tests whether a mobility program helps older adults stay strong and avoid frailty during a hospital stay. If you are 50 or older and expect to be in the hospital for at least 3 days, this study may offer extra support to keep you moving.
This trial tests a personalized exercise program for frail adults aged 60 and older. It uses a tool called Goal Attainment Scaling to measure if the program helps improve physical function.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.